Cryo-Cell International, Inc. CCEL 深 滬
等待開盤 10-03 09:30:00 美东时间
4.53
-0.070
-1.52%
華盛通- 最 高4.62
- 今 開4.6177
- 成交量 1.04万股
- 最 低 4.51
- 昨 收 4.60
- 總市值 3661.24万
- 52周最高 8.78
- 市盈率 靜 92.45
- 換手率 0.13%
- 52周最低 4.09
- 委 比 81.00%
- 總股本 808.22万
- 歷史最高 12.61
- 量 比 1.11
- 振 幅 2.39%
- 歷史最低 2.04
- 每 手 1
- 風險率 1.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cryo-Cell Schedules 2025 Annual Stockholders Meeting
Cryo-Cell International ( ($CCEL) ) has provided an announcement. Cryo-Cell Int...
09-11 05:33
Cryo-Cell International Q2 EPS $0.04 Beats $(0.05) Estimate, Sales $7.929M Miss $8.041M Estimate
Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.05) by 180 percent. This is a 50 percent decrease over earnings of $0.08 per share
07-16 05:04
Cryo-Cell Faces License Termination by Duke University
Cryo-Cell International ( ($CCEL) ) has issued an update. Cryo-Cell Internation...
05-23 05:36
美股大行评级 | 富国银行：维持艾伯维"超配"评级，目标价从210美元升至240美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1104327819967434752.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Syndax制药(SNDX)"超配"评级，目标价从35美元升至39美元</p> <p>• 摩根大通：维持AnaptysBio(ANAB)"超配"评级，目标价从36美元升至42美元</p> <p>• 摩根大通
03-06 11:20
美股大行评级 | 美银证券：维持艾伯维"中性"评级，目标价从200美元升至223美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1103964892578983937.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Syndax制药(SNDX)"超配"评级，目标价从35美元升至39美元</p> <p>• 摩根大通：维持Apellis Pharmaceuticals(APLS)"超配"评级，目标价从50美元升至54美元</
03-05 09:55
Jupiter's Burnout: Can TILT Holdings Reverse Its Five-Year Vape Decline?
TILT's financial health is constrained by $62 million in debt, along with $44 million in lease obligations.
2024-11-23 04:17
CRYO-CELL International declares $0.25 dividend
CRYO-CELL International (NYSE:CCEL) declares $0.25/share quarterly dividend. Forward yield 17.18% Payable Nov. 29; for shareholders of record Nov. 15; ex-div Nov. 15. See CCEL Dividend Scorecard, Yiel...
2024-10-30 20:59
Earnings week ahead: PepsiCo, Delta Air Lines, JPMorgan, Citigroup and more
Next week marks the beginning of earnings season, with several big companies across the financial, consumer and technology sectors set to release their quarterly results. Investors will be keenly watc...
2024-07-07 20:02
Cryo-Cell International(CCEL.US)：2024年Q1财报实现营收785万美元，前值为782万美元，预期值为793万美元；每股收益为0.07美元，前值为0.09美元，预期值为-0.02美元。
Cryo-Cell International(CCEL.US)：2024年Q1财报实现营收785万美元，前值为782万美元，预期值为793万美元；每股收益为...
2024-04-16 06:51
Cryo-Cell International Announces Strategic Subsidiary Spin-Off Plans
Cryo-Cell International Inc (CCEL) has provided an announcement. Cryo-Cell Inte...
2024-03-26 20:44
